294860-58-5

Usage

Uses

Used in Scientific Research:
Methyl 2-(5-bromo-2-methoxyphenyl)acetate is utilized as a research compound for its unique properties, particularly in the study of crystal formation and the investigation of its chemical structure. Its role in scientific research is vital for understanding the behavior of similar organic compounds and their potential applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, methyl 2-(5-bromo-2-methoxyphenyl)acetate is used as an intermediate compound in the synthesis of various drugs. Its unique chemical structure allows for the development of new therapeutic agents, potentially leading to advancements in medicine.
Used in Chemical Synthesis:
Methyl 2-(5-bromo-2-methoxyphenyl)acetate is employed as a key component in the synthesis of other organic compounds. Its versatility in chemical reactions makes it a valuable asset in the production of various chemical products, including specialty chemicals and materials.
Used in Material Science:
In the field of material science, methyl 2-(5-bromo-2-methoxyphenyl)acetate is used as a precursor in the development of new materials with specific properties. Its ability to induce crystal formation makes it an interesting candidate for the creation of materials with tailored characteristics for various applications.

Upstream product

• 67-56-1 methanol 
• 7017-48-3 2-(5-bromo-2-methoxyphenyl)acetic acid 
• 7062-40-0 1-(cyanomethyl)-2-methoxy-6-bromobenzene 

Downstream Products

• 478375-44-9 methyl 2-(2-methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate 

Relevant academic research and scientific papers

TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula I [Formula should be inserted here] and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leuke

TRIAZOLONE COMPOUNDS AND USES THEREOF

The invention disclosed herein is directed to compounds of Formula (I) and pharmaceutically acceptable salts thereof, which are useful in the treatment of prostate, breast, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention also comprises pharmaceutical compositions comprising a therapeutically effective amount of compound of Formula (I), or a pharmaceutically acceptable salt thereof. The invention disclosed herein is also directed to methods of treating prostate, breast, ovarian, liver, kidney, colon, pancreatic, human chronic lymphocytic leukemia, melanoma and other cancers. The invention disclosed herein is further directed to methods of treating prostate, breast, colon, pancreatic, chronic lymphocytic leukemia, melanoma and other cancers comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist. The compounds and pharmaceutical compositions of the invention are also useful in the treatment of viral infections, such as HCV infections and HIV infections. The invention disclosed herein is also directed to a methods of preventing the onset of and/or recurrence of acute and chronic myeloid leukemia, as well as other cancers, comprising administration of a of a therapeutically effective amount of a selective PPARα antagonist.

ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such a

TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE

Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

SPIRO IMIDAZOLE DERIVATIVES AS PPAR MODULATORS

The invention provides compounds (Ia), (Ib) and (Ic), pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated